Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA)

112 filings reported holding CNTA - Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share as of Q3 2024.
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 109M shares of 147M outstanding shares and own 73.69% of the company stock.
Largest 10 shareholders include Medicxi Ventures Management (Jersey) Ltd (20M shares), GENERAL ATLANTIC, L.P. (9.68M shares), PERCEPTIVE ADVISORS LLC (6.28M shares), First Light Asset Management, LLC (5.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.68M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.2M shares), Vida Ventures Advisors, LLC (3.93M shares), T. Rowe Price Investment Management, Inc. (3.56M shares), Siren, L.L.C. (3.26M shares), and EcoR1 Capital, LLC (3.22M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.